In this study, we explored the cytotoxicity of a human NK cell line genetically modified to improve DR5 targeting (TRAILv-KHYG-1 cells) against human ovarian cancer cell lines, OVCAR-3 and SKOV-3 (Fig. 1A) in vitro. The gene discussed is TNFRSF10B; the disease is ovarian cancer.